Hepatitis C Virus (HCV) 

The U.S. CDC recommends that all adults should be screened for HCV at least once in their lifetime, except in settings where the prevalence is below 0.1%. The recommended first-line test is an FDA-approved anti-HCV antibody assay, followed by nucleic acid testing to confirm active infection, especially for those who are immunocompromised or recently exposed  

New from Hytest: High-Quality Recombinant HCV NS3 Antigen  

Hytest is proud to introduce its recombinant HCV NS3 antigen (Cat. #8HC53)— a high-purity antigen developed as capture or detection material for use in immunoassays designed to qualitatively detect antibodies to HCV. It is an ideal choice for customers working on ELISA, LF, CLIA platforms. This reagent supports the creation of sensitive, specific, and reliable diagnostic solutions that align with global HCV screening and elimination strategies. 

Cat# 8HC53 - HCV, NS3 Antigen

*Terms: The special offer opportunity is only available to end users. Institutes and universities are not included in this promotion. The usual shipping and handling costs will still apply. When ordering online, write infectious to the remarks field and select invoice or prepayment invoice as a payment method on the checkout page. The opportunity is a one-time evaluation possibility, feedback about the evaluation results is expected and you can get more details by contacting Hytest customer service at hytest@hytest.fi. Please be informed that research samples provided free of charge may be subject to taxes and duties in some countries. The campaign is not valid for antigens, except Cat# 8HC53, HCV antigen.